Annual Immunisation Coverage Report 2017
Annual Immunisation Coverage Report 2017
复制标题
DOI：
10.33321/cdi.2019.43.47
复制
发表时间：
2019-11-18
影响因子：
2.5
通讯作者：
Beard, Frank
中科院分区：
文献类型：
--
作者：
Hull, Brynley;Hendry, Alexandra;Beard, Frank
第十一次国家年度免疫覆盖率报告重点关注来自澳大利亚免疫登记册（AIR）和国家人乳头瘤病毒（HPV）疫苗接种计划登记册的2017日历年数据。这是第一份报告，包括在原住民和托雷斯海峡岛民（土著）青少年HPV疫苗课程完成的数据。2017年12月，12个月评估年龄的“完全免疫”疫苗接种覆盖率增加到93.8%，60个月评估年龄达到94.5%。2017年12月，24个月评估年龄的“完全免疫”覆盖率略微下降至89.8%，此前2016年12月进行了修订，要求在18个月时接种第四剂DTPa疫苗。2017年12月，土着儿童12个月和60个月的“完全免疫”覆盖率达到有史以来的最高水平，分别为93.2%和96.9%。2017年，与10-19岁的非土著青少年相比，土著青少年第二剂麻疹-腮腺炎-风疹疫苗的补充接种活动要高得多（分别为20.3%和6.4%，以前没有接受过该剂量）。2017年，80.2%的15岁女性和75.9%的15岁男性接受了三剂人乳头瘤病毒（HPV）疫苗的完整疗程。在接受第一剂疫苗的人中，2017年15岁的土著女孩和男孩分别有79%和77%完成了三剂疫苗，而非土著女孩和男孩分别为91%和90%。计划在今后单独编写一份报告，介绍成人空气污染数据，并评估报告的完整性。
This eleventh national annual immunisation coverage report focuses on data for the calendar year 2017 derived from the Australian Immunisation Register (AIR) and the National Human Papillomavirus (HPV) Vaccination Program Register. This is the first report to include data on HPV vaccine course completion in Aboriginal and Torres Strait Islander (Indigenous) adolescents. 'Fully immunised' vaccination coverage in 2017 increased at the 12-month assessment age reaching 93.8% in December 2017, and at the 60-month assessment age reaching 94.5%. 'Fully immunised' coverage at the 24-month assessment age decreased slightly to 89.8% in December 2017, following amendment in December 2016 to require the fourth DTPa vaccine dose at 18 months. 'Fully immunised' coverage at 12 and 60 months of age in Indigenous children reached the highest ever recorded levels of 93.2% and 96.9% in December 2017. Catch-up vaccination activity for the second dose of measles-mumps-rubella-containing vaccine was considerably higher in 2017 for Indigenous compared to non-Indigenous adolescents aged 10-19 years (20.3% vs. 6.4%, respectively, of those who had not previously received that dose). In 2017, 80.2% of females and 75.9% of males aged 15 years had received a full course of three doses of human papillomavirus (HPV) vaccine. Of those who received dose one, 79% and 77% respectively of Indigenous girls and boys aged 15 years in 2017 completed three doses, compared to 91% and 90% of non-Indigenous girls and boys, respectively. A separate future report is planned to present adult AIR data and to assess completeness of reporting.